Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Aug 3:11:1210102.
doi: 10.3389/fpubh.2023.1210102. eCollection 2023.

Risk of secondhand smoke exposure and severity of COVID-19 infection: multicenter case-control study

Collaborators, Affiliations
Multicenter Study

Risk of secondhand smoke exposure and severity of COVID-19 infection: multicenter case-control study

Surekha Kishore et al. Front Public Health. .

Abstract

Introduction: Exposure to secondhand smoke (SHS) is an established causal risk factor for cardiovascular disease (CVD) and chronic lung disease. Numerous studies have evaluated the role of tobacco in COVID-19 infection, severity, and mortality but missed the opportunity to assess the role of SHS. Therefore, this study was conducted to determine whether SHS is an independent risk factor for COVID-19 infection, severity, mortality, and other co-morbidities.

Methodology: Multicentric case-control study was conducted across six states in India. Severe COVID-19 patients were chosen as our study cases, and mild and moderate COVID-19 as control were evaluated for exposure to SHS. The sample size was calculated using Epi-info version 7. A neighborhood-matching technique was utilized to address ecological variability and enhance comparability between cases and controls, considering age and sex as additional matching criteria. The binary logistic regression model was used to measure the association, and the results were presented using an adjusted odds ratio. The data were analyzed using SPSS version 24 (SPSS Inc., Chicago, IL, USA).

Results: A total of 672 cases of severe COVID-19 and 681 controls of mild and moderate COVID-19 were recruited in this study. The adjusted odds ratio (AOR) for SHS exposure at home was 3.03 (CI 95%: 2.29-4.02) compared to mild/moderate COVID-19, while SHS exposure at the workplace had odds of 2.19 (CI 95%: 1.43-3.35). Other factors significantly related to the severity of COVID-19 were a history of COVID-19 vaccination before illness, body mass index (BMI), and attached kitchen at home.

Discussion: The results of this study suggest that cumulative exposure to secondhand cigarette smoke is an independent risk factor for severe COVID-19 illness. More studies with the use of biomarkers and quantification of SHS exposure in the future are needed.

Keywords: COVID-19; secondhand smoke; smoking; substance abuse; vaccination.

PubMed Disclaimer

Conflict of interest statement

VS was employed by Campaign for Tobacco-Free Kids. OB was employed by Global Health Advocacy Incubator. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Sites that participated in the study.

References

    1. World Health Organization WHO Coronavirus (COVID-19) Dashboard. Available online at: https://covid19.who.int/ (accessed December 12, 2022).
    1. World Health Organization Coronavirus Disease (COVID-19) Pandemic. Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (accessed December 12, 2022).
    1. World Health Organization World health Organisation Statement: Tobacco Use and COVID-19 2020. Geneva: World Health Organization.
    1. Centers for Disease Control and Prevention . Coronavirus Disease 2019: People With 21 Certain Medical Conditions 2020. (2020). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-... (accessed December 12, 2022).
    1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271–80. 10.1016/j.cell.2020.02.052 - DOI - PMC - PubMed

Publication types